Current Neuro-Oncology
Volume
26 Number 4
29 February 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 4, 29 February
Clarke
JJ, Halkett GKB, McDougall E, Dhillon HM, Lobb E, Phillips JL,
Hudson P, Nowak AK.
What
do carers of people with high-grade glioma perceive could improve
their preparedness to care, and what additional support do they
require?
Neurooncol
Pract.
2024 Feb 16;11(3):296-306. doi:
10.1093/nop/npae015. PMID:
38737602. Observational study˰ ˍ
Dasgupta P, Ou A, Lin H, Gregory T, Alfaro-Munoz KD, Yuan Y,
Afshar-Khargan V, Kamiya-Matsuoka C, Rousseau JF, Majd NK.
The
risk and burden of thromboembolic and hemorrhagic events in
patients with malignant gliomas receiving bevacizumab.
J
Neurooncol. 2024 Feb 19. doi:
10.1007/s11060-023-04551-9. PMID:
38372903. Observational study. ˍ
Papangelopoulou D, Bison B, Behrens L, Bailey S, Ansari M, Ehlert
K, Martinez OC, Kramm CM, Morales La Madrid A, von Bueren
AO.
Brain stem tumors in children less
than 3 months: Clinical and radiologic findings of a rare
disease.
Childs
Nerv Syst. 2024 Feb 20. doi:
10.1007/s00381-023-06272-w. PMID:
38376530. Observational study. ˍ
Jiang J, Li WB, Xiao SW.
Prognostic
factors analysis of diffuse midline glioma.
J
Neurooncol. 2024 Feb 21. doi:
10.1007/s11060-024-04605-6. PMID:
38381257. Observational study. ˍ
Ma H, Zeng S, Xie D, Zeng W, Huang Y, Mazu L, Zhu N, Yang Z, Chu
J, Zhao J.
Looking through the imaging
perspective: the importance of imaging necrosis in glioma
diagnosis and prognostic prediction - single centre
experience.
Radiol
Oncol. 2024 Feb 21;58(1):23-32. doi:
10.2478/raon-2024-0014. PMID:
38378035. Observational study. ˍ
Samargia-Grivette S, Hartley H, Walsh K, Lemiere J, Payne AD,
Litke E, Knight A.
REhabilitation
Approaches in CHildren with cerebellar mutism syndrome (REACH): An
international cross-disciplinary survey study.
J
Pediatr Rehabil Med. 2024 Feb 21. doi:
10.3233/PRM-230006. PMID:
38393929. Observational study. ˍ
Ebad Ur Rehman M, Faraz F, Cheema HA, Ashruf OS, Raheel H, Naqvi
SZA, Jabeen N, Abid A, Mumtaz Malik H, Iftikhar A, Ibrahim A, Swed
S.
Impact of prior cancer history on
survival in brain malignancy: A propensity score-adjusted,
population-based study.
Cancer
Rep (Hoboken). 2024 Feb 22;7(2):e1984. doi:
10.1002/cnr2.1984. PMID:
38389401. Observational study. ˍ
Miccio JA, Tian Z, Mahase SS, Lin C, Choi S, Zacharia BE, Sheehan
JP, Brown PD, Trifiletti DM, Palmer JD, Wang M, Zaorsky
NG.
Estimating the risk of brain
metastasis for patients newly diagnosed with cancer.
Commun
Med (Lond). 2024 Feb 22;4(1):27. doi:
10.1038/s43856-024-00445-7. PMID:
38388667. Observational study. ˍ
Yilmaz MT, Kahvecioglu A, Yazici G, Mohammadipour S, Kertmen N,
Cifci GC, Zorlu F.
Hypofractionated
stereotactic re-irradiation for progressive glioblastoma: twelve
years' experience of a single center.
J
Neurooncol. 2024 Feb 22. doi:
10.1007/s11060-024-04607-4. Epub ahead of print. PMID:
38383875. Observational study. ˍ
Carpentier A, Stupp R, Sonabend AM, Dufour H, Chinot O, Mathon B,
Ducray F, Guyotat J, Baize N, Menei P, de Groot J, Weinberg JS,
Liu BP, Guemas E, Desseaux C, Schmitt C, Bouchoux G, Canney M,
Idbaih A.
Repeated blood-brain barrier
opening with a nine-emitter implantable ultrasound device in
combination with carboplatin in recurrent glioblastoma: a phase
I/II clinical trial.
Nat
Commun. 2024 Feb 23;15(1):1650. doi:
10.1038/s41467-024-45818-7. PMID:
38396134. Interventional study. ˍ
Odia Y, Koschmann C, Vitanza NA, de Blank P, Aguilera D, Allen J,
Daghistani D, Hall M, Khatib Z, Kline C, MacDonald T, Mueller S,
Faison SL, Allen JE, Naderer OJ, Ramage SC, Tarapore RS, McGovern
SL, Khatua S, Zaky W, Gardner SL.
Safety
and pharmacokinetics of ONC201 (dordaviprone) administered two
consecutive days per week in pediatric patients with H3K27M-mutant
glioma.
Neuro
Oncol. 2024 Feb 24:noae001. doi:
10.1093/neuonc/noae001. PMID:
38400780. Interventional study. ˍ
Beangklang R, Sitthinamsuwan B, Tansirisithikul C, Nunta-Aree
S.
Hydrocephalus following Brain Tumor
Surgery: Factors Correlating with Occurrence of Postoperative
Hydrocephalus and Predictive Scoring Model.
Asian
J Neurosurg. 2024 Feb 26;19(1):44-51. doi:
10.1055/s-0044-1779345. PMID:
38751388. Observational study. ˍ
Lee C, Byeon Y, Kim GJ, Jeon J, Hong CK, Kim JH, Kim YH, Cho YH,
Hong SH, Chong SJ, Song SW.
Exploring
prognostic factors and treatment strategies for long-term survival
in pleomorphic xanthoastrocytoma patients.
Sci
Rep. 2024 Feb 26;14(1):4615. doi:
10.1038/s41598-024-55202-6. PMID:
38409363. Observational study. ˍ
Rastogi A, Brugnara G, Foltyn-Dumitru M, Mahmutoglu MA, Preetha
CJ, Kobler E, Pflüger I, Schell M, Deike-Hofmann K, Kessler
T, van den Bent MJ, Idbaih A, Platten M, Brandes AA, Nabors B,
Stupp R, Bernhardt D, Debus J, Abdollahi A, Gorlia T, Tonn JC,
Weller M, Maier-Hein KH, Radbruch A, Wick W, Bendszus M, Meredig
H, Kurz FT, Vollmuth P.
Deep-learning-based
reconstruction of undersampled MRI to reduce scan times: a
multicentre, retrospective, cohort study.
Lancet
Oncol. 2024 Feb 26;25(3):400-410. doi:
10.1016/S1470-2045(23)00641-1. PMID:
38423052. Observational study. ˍ
*Hiller-Vallina S, Mondejar-Ruescas L, Caamaño-Moreno M,
Cómitre-Mariano B, Alcivar-López D, Sepulveda JM,
Hernández-Laín A, Pérez-Núñez
Á, Segura-Collar B, Gargini R.
Sexual-biased
necroinflammation is revealed as a predictor of bevacizumab
benefit in Glioblastoma.
Neuro
Oncol. 2024 Feb 27:noae033. doi:
10.1093/neuonc/noae033. PMID:
38411438. Observational study. ˍ
Miele E, Anghileri E, Calatozzolo C, Lazzarini E, Patrizi S,
Ciolfi A, Pedace L, Patanè M, Abballe L, Paterra R,
Maddaloni L, Barresi S, Mastronuzzi A, Petruzzi A, Tramacere I,
Farinotti M, Gurrieri L, Pirola E, Scarpelli M, Lombardi G,
Villani V, Simonelli M, Merli R, Salmaggi A, Tartaglia M, Silvani
A, DiMeco F, Calistri D, Lamperti E, Locatelli F, Indraccolo S,
Pollo B.
Clinicopathological and
molecular landscape of 5-year IDH-wild-type glioblastoma
survivors: A multicentric retrospective study.
Cancer
Lett. 2024 Feb 27:216711. doi:
10.1016/j.canlet.2024.216711. PMID:
38423245. Observational study˰
ˍ
Nguyen AV, Soto JM, Digbeu BD, Nguyen CY, Wu E, Huang JH, Kuo
YF.
Factors associated with longer
survival among older medicare patients after diagnosis of
supratentorial primary brain malignancies: a retrospective cohort
study.
Neurol
Res. 2024 Feb 28:1-12. doi:
10.1080/01616412.2024.2323335. PMID:
38415699. Observational study˰
ˍ
Saito N, Hirai N, Sato S, Hayashi M, Iwabuchi S.
Delayed
Pseudoprogression in Glioblastoma Patients Treated With
Tumor-Treating Fields.
Cureus.
2024 Feb 28;16(2):e55147. doi:
10.7759/cureus.55147. PMID:
38558596. Case report. ˍ